Yungshin Global Holding Corp operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Yungshin Global Holding Corp with three other
companies in this sector in Taiwan:
China Chemical and Pharmaceutical Company Limited
sales of 7.58 billion Taiwanese Dollars [US$246.28 million]
of which 67%
Tci Co Ltd
(8.10 billion Taiwanese Dollars [US$263.12 million]
of which 76%
was Asia), and
Lotus Pharmaceutical Co.,Ltd.
(6.43 billion Taiwanese Dollars [US$208.87 million]
of which 97%
was Western Medicine Manufacture).
Yungshin Global Holding Corp reported sales of 7.51 billion Taiwanese Dollars (US$244.12 million)
December of 2018.
increase of 13.5%
versus 2017, when the company's sales were 6.62 billion Taiwanese Dollars.
Sales at Yungshin Global Holding Corp have increased during each of the previous five years
(and since 2013, sales have increased a total of 48%).
Sales of China Mainland District saw an increase
that was more than double the company's growth rate: sales were up
76.1% in 2018, from
637.02 million Taiwanese Dollars to 1.12 billion Taiwanese Dollars.
Not all segments of Yungshin Global Holding Corp experienced an increase in sales in 2018:
sales of Japanese District fell 5.5% to 604.47 million Taiwanese Dollars.